151
Views
18
CrossRef citations to date
0
Altmetric
Review Articles

An overview of in vivo toxicological profile of thymoquinone

, &
Pages 115-122 | Received 21 Jun 2018, Accepted 19 Aug 2018, Published online: 28 Sep 2018

References

  • Abdel-Daim, M.M. and Ghazy, E.W., 2015. Effects of Nigella sativa oil and ascorbic acid against oxytetracycline-induced hepato-renal toxicity in rabbits. Iranian journal of basic medical sciences, 18 (3), 221.
  • AbuKhader, M.M., 2012. The effect of route of administration in thymoquinone toxicity in male and female rats. Indian journal of pharmaceutical sciences, 74 (3), 195–200.
  • AbuKhader, M.M., et al., 2013. Acute effects of thymoquinone on the pregnant rat and embryo-fetal development. Drug and chemical toxicology, 36 (1), 27–34.
  • Ahmad, A., et al., 2013. A review on therapeutic potential of Nigella sativa: a miracle herb. Asian Pacific journal of tropical biomedicine, 3 (5), 337–352.
  • Al Mofleh, I.A., et al., 2008. Gastroprotective effect of an aqueous suspension of black cumin Nigella sativa on necrotizing agents-induced gastric injury in experimental animals. Saudi journal of gastroenterology, 14 (3), 128.
  • Al-Ali, A., et al., 2008. Oral and intraperitoneal LD50 of thymoquinone, an active principle of Nigella sativa, in mice and rats. Journal of Ayub medical college, Abbottabad, 20 (2), 25–27.
  • Alenzi, F., et al., 2010. Protective effects of Nigella sativa oil and thymoquinone against toxicity induced by the anticancer drug cyclophosphamide. British journal of biomedical science, 67 (1), 20–28.
  • Amin, B. and Hosseinzadeh, H., 2015. Black cumin (Nigella sativa) and its active constituent, thymoquinone: an overview on the analgesic and anti-inflammatory effects. Planta medica, 82 (01/02), 8–16.
  • Badary, O.A., et al., 1998. Acute and subchronic toxicity of thymoquinone in mice. Drug development research, 44 (2–3), 56–61.
  • Bamosa, A.O., et al., 2002. The effect of thymoquinone on blood lipids in rats. Indian journal of physiology and pharmacology, 46 (2), 195–201.
  • Benkaci-Ali, F., et al., 2007. Chemical composition of seed essential oils from Algerian Nigella sativa extracted by microwave and hydrodistillation. Flavour and fragrance journal, 22 (2), 148–153.
  • Bolton, J.L., et al., 2000. Role of quinones in toxicology. Chemical research in toxicology, 13 (3), 135–160.
  • Daba, M.H. and Abdel-Rahman, M.S., 1998. Hepatoprotective activity of thymoquinone in isolated rat hepatocytes. Toxicology letters, 95 (1), 23–29.
  • Dajani, E.Z., et al., 2016. Overview of the pre-clinical pharmacological properties of Nigella sativa (Black seeds): a complementary drug with historical and clinical significance. Journal of physiology and pharmacology, 67 (6), 801–817.
  • Dehkordi, F.R. and Kamkhah, A.F., 2008. Antihypertensive effect of Nigella sativa seed extract in patients with mild hypertension. Fundamental & clinical pharmacology, 22 (4), 447–452.
  • El-Dakhakhny, M., 1963. Studies on the chemical constitution of Egyptian Nigella sativa L. seeds. II1. The essential oil. Planta medica, 11 (04), 465–470.
  • El-Dakhakhny, M., 1965. Studies on the Egyptian Nigella sativa L. IV. Some pharmacological properties of the seeds' active principle in comparison to its dihydro compound and its polymer. Arzneimittelforschung, 15 (10), 1227–1229.
  • El-Najjar, N., et al., 2010. Reactive oxygen species mediate thymoquinone-induced apoptosis and activate ERK and JNK signaling. Apoptosis, 15 (2), 183–195.
  • Fakhoury, I., et al., 2016. Uptake, delivery, and anticancer activity of thymoquinone nanoparticles in breast cancer cells. Journal of nanoparticle research, 18 (7), 210.
  • Gali-Muhtasib, H., et al., 2006. Thymoquinone: a promising anti-cancer drug from natural sources. The international journal of biochemistry & cell biology, 38 (8), 1249–1253.
  • Gökçe, A., et al., 2010. Protective effect of thymoquinone in experimental testicular torsion. Urologia internationalis, 85 (4), 461–465.
  • Harzallah, H.J., et al., 2012. Oxidative and genotoxic effects of thymoquinone, Nigella sativa active compound, in Balb/c mice. African journal of food science, 6 (22), 529–534.
  • Javidi, S., et al., 2016. A review of neuropharmacology effects of Nigella sativa and its main component, thymoquinone. Phytotherapy research, 30 (8), 1219–1229.
  • Kanter, M., 2008. Nigella sativa and derived thymoquinone prevents hippocampal neurodegeneration after chronic toluene exposure in rats. Neurochemical research, 33 (3), 579.
  • Karimi, G., et al., 2011. Protective effects of aqueous and ethanolic extracts of Nigella sativa L. and Portulaca oleracea L. on free radical induced hemolysis of RBCs. DARU, 19 (4), 295.
  • Khader, M., et al., 2009. In vitro toxicological properties of thymoquinone. Food and chemical toxicology, 47 (1), 129–133.
  • Kumara, S.S.M. and Huat, B.T.K., 2001. Extraction, isolation and characterisation of antitumor principle, α-hederin, from the seeds of Nigella sativa. Planta medica, 67 (1), 29–32.
  • Landa, P., et al., 2009. In vitro anti-inflammatory activity of carvacrol: inhibitory effect on COX-2 catalyzed prostaglandin E 2 biosynthesis. Archives of pharmacal research, 32 (1), 75–78.
  • Mansour, M., et al., 2001. Effects of volatile oil constituents of Nigella sativa on carbon tetrachloride-induced hepatotoxicity in mice: evidence for antioxidant effects of thymoquinone. Research communications in molecular pathology and pharmacology, 110 (3–4), 239–252.
  • Mansour, M.A., et al., 2002. Effects of thymoquinone on antioxidant enzyme activities, lipid peroxidation and DT‐diaphorase in different tissues of mice: a possible mechanism of action. Cell biochemistry and function, 20 (2), 143–151.
  • Mehri, S., et al., 2014. Neuroprotective effect of thymoquinone in acrylamide-induced neurotoxicity in Wistar rats. Iranian journal of basic medical sciences, 17 (12), 1007.
  • Meral, I., et al., 2001. Effect of Nigella sativa on glucose concentration, lipid peroxidation, anti‐oxidant defence system and liver damage in experimentally‐induced diabetic rabbits. Journal of veterinary medicine series A, 48 (10), 593–599.
  • Morsi, N.M., 2000. Antimicrobial effect of crude extracts of Nigella sativa on multiple antibiotics-resistant bacteria. Acta microbiologica polonica, 49 (1), 63–74.
  • Ong, Y.S., et al., 2016. Acute and subacute toxicity profiles of thymoquinone-loaded nanostructured lipid carrier in BalB/c mice. International journal of nanomedicine, 11, 5905.
  • Salem, E.M., et al., 2010. Comparative study of Nigella Sativa and triple therapy in eradication of Helicobacter pylori in patients with non-ulcer dyspepsia. Saudi journal of gastroenterology, 16 (3), 207.
  • Shakeri, F., et al., 2016. Gastrointestinal effects of Nigella sativa and its main constituent, thymoquinone: a review. Avicenna journal of phytomedicine, 6 (1), 9–20.
  • Tembhurne, S., et al., 2014. A review on therapeutic potential of Nigella sativa (kalonji) seeds. Journal of medicinal plants research, 8 (3), 167–177.
  • Terzi, A., et al., 2010. Protective effects of Nigella sativa on intestinal ischemia-reperfusion injury in rats. Journal of investigative surgery, 23 (1), 21–27.
  • Thomas, T.J., et al., 2002. Antitumour property and toxicity of Barringtonia racemosa Roxb seed extract in mice. Journal of ethnopharmacology, 82 (2–3), 223–227.
  • Tubesha, Z., et al., 2013. Study on the potential toxicity of a thymoquinone-rich fraction nanoemulsion in Sprague Dawley rats. Molecules (Basel, Switzerland), 18 (7), 7460–7472.
  • Yu, S.-M. and Kim, S.-J., 2015. The thymoquinone-induced production of reactive oxygen species promotes dedifferentiation through the ERK pathway and inflammation through the p38 and PI3K pathways in rabbit articular chondrocytes. International journal of molecular medicine, 35 (2), 325–332.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.